AIDS Therapies
World AIDS Series: Hit HIV-1 Hard, But Only When Necessary
Published in AIDS Weekly, July 3rd, 2000
This is the subject of the fourth in a series of six articles published by The Lancet in the build-up to the World AIDS 2000 Conference in Durban, South Africa, July 9-14.
Patients' activist Mark Harrington and clinician Charles Carpenter discuss data that justify a balanced approach and the feasibility of randomized controlled trials to provide clearer answers about when to start HIV drug treatment.
Current data show that combination antiretroviral therapy for HIV-1 infection benefits people with CD4 cell counts less than 350 cells/(mu)L. Based on currently...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2000-07-03)
More Articles from AIDS Weekly
- Prognostics
Serum Albumin Predicts Survival in HIV Infected Women - AIDS Therapies
Short-Course Antiretroviral Therapy Could Help Reduce HIV-1 Substantially, But is Still Unaffordable - Coinfection
Interferon-(alpha)2b and Ribavirin Evaluated in HCV/HIV Infected Patients - Disease Associations
Clinical Course of Cardiomyopathy in HIV Patients Examined - Epidemiology
Science Issue Focuses on AIDS Research in Africa - Kaposi's Sarcoma
Herpesvirus Sabotages Immune System with a New and Unusual Strategy - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
